A Primer on Continuous Renal Replacement Therapy for Critically Ill Patients

No abstract is available for this paper.

• Publication year

  1998

• Venue

  The Annals of Pharmacotherapy

• Publication date

  1998-03-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1345/aph.17105PMID 9533067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An evaluation of ultrafiltration as treatment of therapy-resistant cardiac edema.

  2009cited by this paper
• Pharmacokinetics of vancomycin during continuous hemodiafiltration

  2005cited by this paper
• Elimination of cefmenoxime during continuous haemofiltration

  2005cited by this paper
• Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD)

  2005cited by this paper
• Pharmacokinetics and dosage recommendations of teicoplanin in patients treated by continuous veno-venous haemodialysis (CVVHD)

  2004cited by this paper
• Cefotiam during continuous haemofiltration

  2004cited by this paper
• Anticoagulation in continuous renal replacement therapy.

  1999cited by this paper
• Vascular access for continuous renal replacement therapy

  1998cited by this paper
• Dialysis prescription and kinetics in acute renal failure.

  1997cited by this paper
• Membrane biocompatibility in the treatment of acute renal failure: what is the evidence in 1996?

  1997cited by this paper
• Predicting mortality in intensive care patients with acute renal failure treated with dialysis.

  1997cited by this paper
• The use of biocompatible dialysis membranes in acute renal failure.

  1997cited by this paper
• Hemodynamic factors in acute renal failure.

  1997cited by this paper
• Initiating and Implementing a Continuous Renal Replacement Therapy Program

  1996cited by this paper
• Pumps Utilized During Continuous Renal Replacement Therapy

  1996cited by this paper
• Quinine Clearance in Continuous Venovenous Hemofiltration

  1996cited by this paper
• CONTINUOUS VENOVENOUS HEMODIALYSIS (CVVHD) CLEARANCE OF CEFTRIAXONE

  1996cited by this paper
• Slow isolated ultrafiltration for the treatment of congestive heart failure

  1996cited by this paper
• Nomenclature for continuous renal replacement therapies

  1996cited by this paper
• Continuous Renal Replacement Therapy: Cost Considerations and Reimbursement

  1996cited by this paper
• Lithium poisoning treated by high-performance continuous arteriovenous and venovenous hemodiafiltration.

  1996cited by this paper
• Continuous Renal Replacement Therapy for Burned Patients: Renal and Systemic Considerations

  1996cited by this paper
• Management of acute renal failure: new perspectives.

  1996cited by this paper
• Continuous Renal Replacement Therapies: Evolution Towards a New Era

  1996cited by this paper
• Acute renal failure.

  1996cited by this paper
• Nutritional Considerations in Continuous Renal Replacement Therapies

  1996cited by this paper
• Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration.

  1996cited by this paper
• Clearance of Ticarcillin‐Clavulanic Acid by Continuous Venovenous Hemofiltration in Three Critically Ill Children, Two With and One Without Concomitant Extracorporeal Membrane Oxygenation

  1996cited by this paper
• The role of continuous renal replacement therapy in the future treatment of acute renal failure

  1996cited by this paper
• The role of continuous renal replacement therapy in sepsis and multiorgan failure

  1996cited by this paper
• Continuous renal replacement therapy in critically Ill pediatric patients

  1996cited by this paper
• Anticoagulation in Continuous Extracorporeal Renal Replacement Therapy

  1996cited by this paper
• Modalities of Dialysis for Acute Renal Failure

  1996cited by this paper
• Solute Control in Acute Renal Failure: Prescription and Delivery of Adequate Extracorporeal Therapy

  1996cited by this paper
• Anticoagulation strategies for continuous renal replacement therapies: What works?

  1996cited by this paper
• Impact of the nutritional regimen on protein catabolism and nitrogen balance in patients with acute renal failure.

  1996cited by this paper
• Complications with continuous renal replacement therapy

  1996cited by this paper
• Management of Drug Dosing in Continuous Renal Replacement Therapy

  1996cited by this paper
• Continuous Renal Replacement Therapy Component Selection: Replacement Fluid and Dialysis Solutions

  1996cited by this paper
• Drug administration in critically ill patients with acute renal failure.

  1995cited by this paper
• Continuous venovenous hemodiafiltration in infants and children.

  1995cited by this paper
• Acute renal replacement in the intensive care unit: now and tomorrow.

  1995cited by this paper
• Continuous hemofiltration as blood purification in sepsis.

  1995cited by this paper
• The management of renal failure in patients at risk of cerebral edema/hypoxia.

  1995cited by this paper
• Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure.

  1995cited by this paper
• Removal of pro-inflammatory cytokines with renal replacement therapy: Sense or nonsense?

  1995cited by this paper
• Prognostic stratification in critically ill patients with acute renal failure requiring dialysis.

  1995cited by this paper
• Continuous hemofiltration for the failing heart.

  1995cited by this paper
• Achievements and new directions in continuous renal replacement therapies.

  1995cited by this paper
• Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration.

  1995cited by this paper
• Clinical Pharmacokinetics During Continuous Haemofiltration

  1994cited by this paper
• Continuous renal replacement therapies in the treatment of acute renal failure in intensive care patients. Part 1. Theoretical aspects and techniques.

  1994cited by this paper
• Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure.

  1994cited by this paper
• Continuous renal replacement therapies in the treatment of acute renal failure in intensive care patients. Part 2. Clinical indications and prescription.

  1994cited by this paper
• Continuous renal replacement therapies in the treatment of acute renal failure in intensive care patients. II: Clinical indications and prescription

  1994cited by this paper
• Effect of Continuous Arteriovenous Hemodiafiltration on the Pharmacokinetics of Fluconazole

  1994cited by this paper
• A review of venovenous haemofiltration in seriously ill infants

  1994cited by this paper
• Effect of Continuous Hemofiltration on Phenytoin Elimination

  1994cited by this paper
• Continuous veno-venous haemofiltration following cardio-pulmonary bypass

  1993cited by this paper
• Cytokines in Plasma and Ultrafiltrate during Continuous Arteriovenous Haemofiltration

  1993cited by this paper
• Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass.

  1993cited by this paper
• Vancomycin and Tobramycin Clearance in an Infant during Continuous Hemofiltration

  1993cited by this paper
• Effect of Continuous Arteriovenous Haemofiltration on Pharmacokinetics of Amrinone

  1993cited by this paper
• Acute renal failure treated by haemofiltration: factors affecting outcome.

  1993cited by this paper
• Prognosis of acute tubular necrosis: an extended prospectively contrasted study.

  1993cited by this paper
• Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration.

  1993cited by this paper
• A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients.

  1993cited by this paper
• Continuous Renal Replacement Is the Preferred Treatment for All Acute Renal Failure Patients Receiving Intensive Care

  1993cited by this paper
• Arteriovenous or Venovenous Continuous Therapies Are Not Superior to Standard Hemodialysis in All Patients with Acute Renal Failure

  1993cited by this paper
• Vascular complications of continuous arteriovenous hemofiltration in trauma patients.

  1993cited by this paper
• Pharmacokinetics of Ganciclovir in Heart Transplant Patients Undergoing Continuous Venovenous Hemodialysis

  1993cited by this paper
• Continuous veno‐venous hemofiltration with dialysis removes cytokines from the circulation of septic patients

  1993cited by this paper
• Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients.

  1993cited by this paper
• Dialysate and blood flow dependence of diffusive solute clearance during CVVHD.

  1992cited by this paper
• Continuous arteriovenous hemofiltration after cardiac operations in infants and children.

  1992cited by this paper
• Gentamicin clearance during continuous arteriovenous hemodiafiltration

  1992cited by this paper
• Intermittent venovenous hemofiltration as a chronic treatment for refractory and intractable heart failure.

  1992cited by this paper
• Pharmacokinetics of ciprofloxacin and vancomycin in patients with acute renal failure treated by continuous haemodialysis.

  1992cited by this paper
• Management of post-traumatic acute renal failure with peritoneal dialysis.

  1992cited by this paper
• Acute renal failure in critical illness. Conventional dialysis versus acute continuous hemodiafiltration.

  1992cited by this paper
• Clearance of atracurium and laudanosine in the urine and by continuous venovenous haemofiltration.

  1991cited by this paper
• The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults.

  1991cited by this paper
• Continuous hemofiltration and hemodiafiltration in the management of multiple organ failure.

  1991cited by this paper
• Drug dosage during continuous hemofiltration: pharmacokinetics and practical implications.

  1991cited by this paper
• Vancomycin pharmacokinetics in acute renal failure: Preservation of nonrenal clearance

  1991cited by this paper
• Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure.

  1991cited by this paper
• Elimination of vancomycin in patients on continuous arteriovenous hemodialysis.

  1991cited by this paper
• Amikacin pharmacokinetics during continuous veno-venous hemofiltration.

  1991cited by this paper
• Pharmacokinetics of cefuroxime and ceftazidime in patients with acute renal failure treated by continuous arteriovenous haemodialysis.

  1991cited by this paper
• Gentamicin and Vancomycin Removal by Continuous Venovenous Hemofiltration

  1991cited by this paper
• Drug removal during continuous hemofiltration or hemodialysis.

  1991cited by this paper
• Hyperlactataemia and metabolic acidosis during haemofiltration using lactate-buffered fluids.

  1991cited by this paper
• Pharmacokinetics of amikacin during continuous veno-venous hemofiltration.

  1990cited by this paper
• Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.

  1990cited by this paper
• Continuous arteriovenous hemodialysis for acute renal failure after cardiac operations.

  1990cited by this paper
• Single-dose kinetics of imipenem/cilastatin during continuous arteriovenous haemofiltration in intensive care patients.

  1989cited by this paper
• Continuous arteriovenous hemofiltration in the treatment of 100 critically ill patients with acute renal failure: report on clinical outcome and nutritional aspects.

  1989cited by this paper
• Vancomycin disposition during continuous arteriovenous hemofiltration.

  1989cited by this paper
• Is continuous haemofiltration superior to intermittent dialysis and haemofiltration treatment?

  1989cited by this paper
• Pharmacokinetics of intravenous cefuroxime during intermittent and continuous arteriovenous hemofiltration.

  1988cited by this paper

• How to perform pharmacokinetic research of antimicrobial drugs in critically ill patients undergoing continuous renal replacement therapy: a scoping review of all relevant pharmacokinetic factors.

  2025cites this paper
• Pharmacokinetics of zanamivir in critically ill patients undergoing continuous venovenous hemofiltration

  2023cites this paper
• “CATCH” Study: Correct Antibiotic Therapy in Continuous Hemofiltration in the Critically Ill in Continuous Renal Replacement Therapy: A Prospective Observational Study

  2022cites this paper
• Electrolyte, acid-base, and medication management with renal replacement therapy.

  2022cites this paper
• Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review

  2022cites this paper
• Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update

  2020cites this paper
• Pharmacological Challenges in Neurocritical Care

  2020cites this paper
• Anti-Infective Agents

  2019cites this paper
• Clinical Application of Pharmacokinetics: Basis for Rational Dose Selection in a Critically Ill Patient on Renal Replacement Therapy

  2018cites this paper
• Critically Ill Patients

  2018cites this paper
• Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous hemodiafiltration on different anticoagulant modalities

  2017cites this paper
• Pharmacokinetics of linezolid during continuous hemodiafiltration: A case report.

  2017cites this paper
• Continuous Renal Replacement Therapy (CRRT)

  2016cites this paper
• Evaluation of Safety and Efficacy of Intravenous Zanamivir in the Treatment of Hospitalized Japanese Patients with Influenza: An Open-Label, Single-Arm Study

  2015cites this paper
• Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children

  2015cites this paper
• Renal Replacement Therapy

  2014cites this paper
• 38 – Principles of Drug Therapy in Patients with Reduced Kidney Function

  2014cites this paper
• Clinical Pharmacokinetics: Applications in Pediatric Practice

  2014cites this paper
• Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study

  2014cites this paper
• Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study

  2013cites this paper
• Untersuchung der Pharmakokinetik von Ciprofloxacin und Piperacillin bei Intensivpatienten mit kontinuierlichen Hämodialyseverfahren

  2013cites this paper
• Vancomycin Clearance in High-Volume Venovenous Hemofiltration

  2013cites this paper
• Management of digoxin therapy using pharmacokinetics in a patient undergoing continuous venovenous hemofiltration.

  2013cites this paper
• [Dosage of antipseudomonal antibiotics in patients with acute kidney injury subjected to continuous renal replacement therapies].

  2013cites this paper
• Continuous Renal Replacement Therapy Clearance Rate for Salicylate Toxicity in Multi-System Trauma *

  2012cites this paper
• Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy

  2012influential citation
• [Antibiotic dose adjustment in the treatment of MRSA infections in patients with acute renal failure undergoing continuous renal replacement therapies].

  2012cites this paper
• Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: A multicentre pharmacokinetic study*

  2012cites this paper
• Understanding Renal Replacement Therapy and Dosing of Drugs in Pediatric Patients with Kidney Disease

  2012cites this paper
• Linezolid Pharmacokinetics in Patients With Acute Renal Failure Undergoing Continuous Venovenous Hemodiafiltration

  2012cites this paper
• Dosificación de antibióticos en el tratamiento de las infecciones por SARM en pacientes con insuficiencia renal aguda sometidos a técnicas continuas de depuración extrarrenal

  2012cites this paper
• Antibacterial Dosing in Intensive Care Pharmacokinetics, Degree of Disease and Pharmacodynamics of Sepsis

  2012cites this paper
• Presence and accuracy of drug dosage recommendations for continuous renal replacement therapy in tertiary drug information references.

  2012cites this paper
• How to Optimize Drug Delivery in Renal Replacement Therapy

  2011cites this paper
• Influence of Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodiafiltration on the Disposition of Doripenem

  2011cites this paper
• Using PK/PD to optimize antibiotic dosing for critically ill patients.

  2011cites this paper
• Pharmacokinetic Assessment of Peramivir in a Hospitalized Adult Undergoing Continuous Venovenous Hemofiltration

  2011cites this paper
• Influencia de las técnicas continuas de sustitución renal en la farmacocinética y dosificación de linezolid en pacientes críticos

  2011cites this paper
• Acute Kidney Injury

  2011cites this paper
• Sepsis: new strategies for management

  2011cites this paper
• Population Pharmacokinetics of Fluconazole in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration: Using Monte Carlo Simulations To Predict Doses for Specified Pharmacodynamic Targets

  2011cites this paper
• Antibiotic dosing during sustained low-efficiency dialysis: Special considerations in adult critically ill patients*

  2011cites this paper
• Drug Therapy in Renal Failure

  2011cites this paper
• Postoperative Respiratory Care

  2011cites this paper
• Pharmacokinetics: Practical Application to Antimicrobial Therapy

  2011influential citation
• Continuous Renal Replacement Therapies: A Brief Primer for the Neurointensivist

  2010cites this paper
• Possible removal of topiramate by continuous renal replacement therapy.

  2010cites this paper
• Continuing Education: Alternative Approaches to Optimizing Antimicrobial Pharmacodynamics in Critically Ill Patients

  2010cites this paper
• Drug dosing in acute kidney injury and during renal replacement therapy

  2010cites this paper
• Use of Methylene Blue for Refractory Septic Shock During Continuous Venovenous Hemodiafiltration

  2010cites this paper
• Drug dosing in the elderly patients with chronic kidney disease.

  2009cites this paper
• Continuous venovenous hemodiafiltration trace element clearance in pediatric patients: a case series

  2009cites this paper
• Handling of Drugs in Children with Abnormal Renal Function

  2009cites this paper
• Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis

  2009cites this paper
• Continuous-Infusion β-Lactam Antibiotics During Continuous Venovenous Hemofiltration for the Treatment of Resistant Gram-Negative Bacteria

  2009cites this paper
• Pharmacotherapy in the Critically Ill Child with Acute Kidney Injury

  2009cites this paper
• Chapter 21 – Principles of Drug Dosing in Critically Ill Patients

  2008cites this paper
• Drug dosage in renal failure

  2008cites this paper
• Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens.

  2008cites this paper
• Dose adjustment and pharmacodynamic considerations for antibiotics in severe sepsis and septic shock

  2008cites this paper
• Amino Acid Requirements in Critically Ill Patients with Acute Kidney Injury Treated with Continuous Renal Replacement Therapy

  2008cites this paper
• Surgical Critical Care: From Old Boundaries to New Frontiers

  2007cites this paper
• Pharmacokinetic Considerations for Antimicrobial Therapy in Patients Receiving Renal Replacement Therapy

  2007cites this paper
• Elimination of Piperacillin and Tazobactam by Renal Replacement Therapies with AN69 and Polysulfone Hemofilters: Evaluation of the Sieving Coefficient

  2006cites this paper
• Continuous Renal Replacement Therapy in Patients following Traumatic Injury

  2006cites this paper
• Antibacterial Dosing in Intensive Care

  2006cites this paper
• Pharmacokinetic changes in critical illness.

  2006cites this paper
• Implementing a standardized safety procedure for continuous renal replacement therapy solutions.

  2006cites this paper
• Adjustment of antimicrobial dosages for continuous venovenous hemofiltration based on patient-specific information.

  2006cites this paper
• Clearance of linezolid via continuous venovenous hemodiafiltration.

  2006cites this paper
• The Effects of Continuous Renal Replacement on Anti-infective Therapy in the Critically Ill

  2005cites this paper
• Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy.

  2005cites this paper
• Pharmacokinetics and Pharmacodynamics of Imipenem during Continuous Renal Replacement Therapy in Critically Ill Patients

  2005cites this paper
• Introduction aux thérapies continues de remplacement rénal et principes d’ajustement des posologies des médicaments

  2004cites this paper
• Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.

  2004cites this paper
• In vitro clearance of trace elements via continuous renal replacement therapy.

  2004cites this paper
• Influence of renal replacement therapy on pharmacokinetics in critically ill patients.

  2004cites this paper
• Drug Dosing During Intermittent Hemodialysis and Continuous Renal Replacement Therapy

  2004cites this paper
• About Drug Dialyzability

  2003cites this paper
• Linezolid Clearance During Continuous Venovenous Hemodiafiltration: A Case Report

  2003cites this paper
• Acute Renal Failure and the Critically Ill Patient

  2002cites this paper
• Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis.

  2002cites this paper
• Pharmacokinetics of Piperacillin-Tazobactam in Anuric Intensive Care Patients during Continuous Venovenous Hemodialysis

  2002cites this paper
• Pharmacokinetics of Levofloxacin During Continuous Venovenous Hemodiafiltration and Continuous Venovenous Hemofiltration in Critically Ill Patients

  2002cites this paper
• Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients

  2001cites this paper
• Pharmacokinetics of levofloxacin during continuous veno-venous hemofiltration

  2001cites this paper
• Splanchnic perfusion during hemodialysis: Evidence for marginal tissue perfusion

  2001cites this paper
• Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration

  2001cites this paper
• Pharmacokinetics of Levofloxacin and Ciprofloxacin during Continuous Renal Replacement Therapy in Critically Ill Patients

  2001cites this paper
• Pharmacokinetic studies in patients on continuous renal replacement therapies

  2001cites this paper
• Pharmacokinetics of Cefepime during Continuous Renal Replacement Therapy in Critically Ill Patients

  2001cites this paper
• Determinants of Ceftazidime Clearance by Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodialysis

  2000cites this paper
• Determinants of Ceftriaxone Clearance by Continuous Venovenous Hemofiltration and Hemodialysis

  2000cites this paper
• Propafenone Disposition during Continuous Venovenous Hemofiltration

  1999cites this paper
• Acute renal failure in the intensive care unit. Therapy overview, patient risk stratification, complications of renal replacement, and special circumstances.

  1999cites this paper
• Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.

  1998cites this paper